CICONE, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.145
AS - Asia 671
EU - Europa 470
SA - Sud America 97
AF - Africa 14
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.405
Nazione #
US - Stati Uniti d'America 1.101
SG - Singapore 426
IT - Italia 175
CN - Cina 151
BR - Brasile 76
GB - Regno Unito 56
SE - Svezia 47
CA - Canada 33
NL - Olanda 31
DE - Germania 27
FR - Francia 27
EE - Estonia 21
HK - Hong Kong 20
RO - Romania 20
VN - Vietnam 19
CZ - Repubblica Ceca 14
GR - Grecia 12
FI - Finlandia 11
IN - India 11
AR - Argentina 7
BD - Bangladesh 7
IR - Iran 7
JP - Giappone 7
MX - Messico 7
ZA - Sudafrica 7
CH - Svizzera 6
AU - Australia 5
LV - Lettonia 5
RU - Federazione Russa 5
CL - Cile 4
EC - Ecuador 4
AT - Austria 3
EU - Europa 3
IL - Israele 3
PK - Pakistan 3
TR - Turchia 3
BE - Belgio 2
CO - Colombia 2
GH - Ghana 2
IQ - Iraq 2
JM - Giamaica 2
KE - Kenya 2
KR - Corea 2
PY - Paraguay 2
TN - Tunisia 2
UA - Ucraina 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ES - Italia 1
ET - Etiopia 1
ID - Indonesia 1
IE - Irlanda 1
JO - Giordania 1
LT - Lituania 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
PR - Porto Rico 1
SA - Arabia Saudita 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 2.405
Città #
Singapore 228
Chandler 181
Hefei 99
Santa Clara 99
Princeton 70
Lawrence 69
Milan 60
Dallas 52
Ashburn 46
Wilmington 46
London 40
Chicago 29
Los Angeles 26
Ottawa 24
Hong Kong 20
Boardman 17
Des Moines 17
Rome 14
The Dalles 12
Timisoara 11
Nijmegen 10
West Jordan 10
Columbus 9
Munich 9
Norwalk 9
Bayonne 8
Belo Horizonte 8
Council Bluffs 8
Hanoi 8
Redmond 8
Horia 7
Boston 6
Hanover 6
Helsinki 6
Lanskroun 6
Mexico City 6
Naples 6
New York 6
Olomouc 6
Redwood City 6
San Francisco 6
Stockholm 6
Beijing 5
Charlotte 5
Guangzhou 5
Ho Chi Minh City 5
Massy 5
Poplar 5
Riga 5
Shanghai 5
São Paulo 5
Turku 5
Ann Arbor 4
Assago 4
Atlanta 4
Isfahan 4
Johannesburg 4
L'aquila 4
New Delhi 4
Oosterbeek 4
Paola 4
San Diego 4
Toronto 4
Wuxi 4
Barcellona Pozzo di Gotto 3
Bologna 3
Brooklyn 3
Caserta 3
Catania 3
Catanzaro 3
Chennai 3
Clearwater 3
Cuijk 3
Paris 3
Seattle 3
Tokyo 3
Utrecht 3
Accra 2
Ankara 2
Antwerp 2
Arezzo 2
Aversa 2
Berlin 2
Brampton 2
Bures-sur-Yvette 2
Campinas 2
Chrudim 2
Cincinnati 2
Denver 2
Duque de Caxias 2
Durban 2
Empoli 2
Fayetteville 2
Florence 2
Fortaleza 2
Foshan 2
Gangi 2
Lamezia Terme 2
Lausanne 2
Lercara Friddi 2
Totale 1.503
Nome #
Volumetric assessment of gliomas: Comparison between F-18-FET and Ga-68-NODAGA-RGDyK 69
Impact of chemotherapy with Temozolomide on physiological brain 18F-DOPA uptake in patients with glioma 62
F-DOPA PET identifies high tumor grade and anaplastic transformation in non-enhancing gliomas 59
Preclinical evaluation of a single-chain variable anti TEM-1 fragment labeled with In-111 and Tb-152 58
In-111-PCTA-VRC07 a Radiolabeled Broadly Neutralizing Antibody For HIV Imaging in Mice 54
A Monte Carlo model for the internal dosimetry of choroid plexuses in nuclear medicine procedures 50
18 F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma 47
18F-DOPA Positron Emission Tomography in Medulloblastoma: 2 Case Reports 46
Central nervous system - Primary tumours 43
Amino acid PET and MR perfusion imaging in brain tumours 43
"Boom-Boom" radioimmunotherapy of lymphomas: Are two magic bullets better than one? 43
Advanced imaging techniques for radiotherapy planning of gliomas 43
Correction to: Preclinical Evaluation and Dosimetry of [111In] CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1) (Molecular Imaging and Biology, (2020), 22, 4, (979-991), 10.1007/s11307-020-01479-8) 42
Central nervous system- Primary and secondary Tumours: Radiolabelled Amino Acids 41
Value of F-DOPA PET in the long term follow up of radionecrotic brain metastases after radiosurgery: comparison with MRI 41
18F-DOpA uptake parameters in glioma: Effects of patients’ characteristics and prior treatment history 40
A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with 90Y-ibritumomab tiuxetan (Zevalin) 40
The contest between internal and external-beam dosimetry: The Zeno's paradox of Achilles and the tortoise 40
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery 39
Anatomical substrates of cognitive and clinical dimensions in first episode schizophrenia 39
Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting 38
Long-term metabolic evolution of brain metastases with suspected radiation necrosis following stereotactic radiosurgery: longitudinal assessment by F-DOPA PET 37
ROLE OF 18F-DOPA PET/CT IN NON-ENHANCING GLIOMAS 36
18F-PSMA-1007 salivary gland dosimetry: comparison between different methods for dose calculation and assessment of inter- and intra-patient variability 36
LONG TERM FOLLOW UP OF RADIONECROTIC BRAIN METASTASES ASSESSED BY SERIAL F-DOPA PET/CT SCANS 35
Cardiac radionuclide imaging in rodents: A review of methods, results, and factors at play 35
Cross-sectional evaluation of FGD-avid polyostotic fibrous dysplasia: MRI, CT and PET/MRI findings 35
Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: The randomized, open-label, crossover, active-comparator FIORE trial 33
Comment on hatzoglou et al: Dynamic contrastenhanced MRI perfusion versus 18FDG PET/CT in differentiating brain tumor progression from radiation injury 33
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands 33
Dosimetry of nuclear medicine therapies: current controversies and impact on treatment optimization 32
Dosimetry-based treatment planning for molecular radiotherapy: A summary of the 2017 report from the Internal Dosimetry Task Force 31
Fatal pulmonary tumour thrombotic microangiopathy: do typical FDG-PET findings exist? 30
Hyperhomocysteinemia in acute iatrogenic hypothyroidism: the relevance of thyroid autoimmunity 30
Comparison of absorbed dose extrapolation methods for mouse-to-human translation of radiolabelled macromolecules 30
Impaired insulin-stimulated myocardial glucose metabolic rate is associated with reduced estimated myocardial energetic efficiency in subjects with different degrees of glucose tolerance 29
Unespected dectection of unruptured brain arteriovenous malformation with 18F-DOPA PET/MR 29
Not all that glitters is COVID! Differential diagnosis of FDG-avid interstitial lung disease in low-prevalence regions 29
Fundamentals of internal radiation dosimetry 28
Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases 28
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group 27
Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI 27
In Reply to the Letter to the Editor Regarding “18F-DOPA PET in Medulloblastoma: Two Case Reports” 27
Functional connectivity of the cortico-subcortical sensorimotor loop is modulated by the severity of nigrostriatal dopaminergic denervation in Parkinson's Disease 26
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials 25
Three-dimensional patient-specific dosimetry in radioimmunotherapy with 90Y-ibritumomab-tiuxetan 25
Repeated amino acid PET imaging for longitudinal monitoring of brain tumors 24
Thyro-entero-gastric autoimmunity: Pathophysiology and implications for patient management 24
Editorial: Nuclear Medicine in the Context of Personalized Medicine 24
Editorial: Perspectives in Small Animal Radionuclide Imaging 24
Internal radiation dosimetry of a 152Tb-labeled antibody in tumor-bearing mice 24
LONGITUDINAL HYBRID PET/MRI IN JUVENILE-ONSET HUNTINGTON DISEASE (JOHD) 24
THE RELATIONSHIP BETWEEN BRAIN STRUCTURE AND GLUCOSE METABOLISM VARIES OVER TIME IN JUVENILE-ONSET HUNTINGTON DISEASE 23
Preclinical Evaluation and Dosimetry of [111In]CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1) 23
Thyro-gastric autoimmunity in patients with differentiated thyroid cancer: a prospective study 23
Single-fraction versus multifraction (3 × 9 gy) stereotactic radiosurgery for large (>2 cm) brain metastases: A comparative analysis of local control and risk of radiation-induced brain necrosis 23
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0 22
Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases 22
Do we need dosimetry for the optimization of theranostics in CNS tumors? 21
First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68 Ga-NODAGA-MJ9 21
Reply to Zaragori et al.: “Is IDH mutation status associated with 18F-FDopa PET uptake” 21
First in-human radiation dosimetry of 68Ga-NODAGA-RGDyK 21
Multiparametric evaluation of low grade gliomas at followup: Comparison between diffusion and perfusion MR with 18F-FDOPA PET 21
Follicular lymphoma at relapse after rituximab containing regimens: Comparison of time to event intervals prior to and after 90Y-ibritumomab-tiuxetan 21
Rituximab-like radiolabelled antibodies for the treatment of non-hodgkin's lymphomas 20
Erratum to: Amino acid PET and MR perfusion imaging in brain tumours (Clinical and Translational Imaging, (2017), 5, 3, (209-223), 10.1007/s40336-017-0225-z) 20
Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey 20
Why not consider PET/CT in the workup of pulmonary tumour thrombotic microangiopathy? 20
Reply to: "assessment of imaging biomarkers in the follow-up of brain metastases after SRS" 20
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry 19
Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors 19
Renal Cell Carcinoma: the Oncologist Asks, Can PSMA PET/CT Answer? 19
FET and FDOPA PET Imaging in Glioma 19
Malignant Lymphoma in Children 19
Metabolic Evolution of Brain Metastasis after Stereotactic Radiosurgery: Mismatch between F-DOPA and FDG PET 19
Tc-99m DTPA cisternography shows disappearance of cerebrospinal fluid leakage after standing a short time 19
Imaging the future: A report from the Young Daily EANM Forum 2013 19
Radioimmunotherapy of heavily pre-treated, non-Hodgkin's lymphoma patients: efficacy and safety in a routine setting 19
The mean striatal 18 F-DOPA uptake is not a reliable cut-off threshold for biological tumour volume definition of glioma 18
The importance of standardizing acquisition settings and interpretation criteria of radionuclide cisternography 18
EANM enabling guide: how to improve the accessibility of clinical dosimetry 17
Immune-related [18F]FDG PET findings in patients undergoing checkpoint inhibitors treatment: correlation with clinical adverse events and prognostic implications 17
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update 17
Expression of large neutral amino acid transporters LAT1 and LAT2 in medulloblastoma 17
Repeated stereotactic radiosurgery for patients with progressive brain metastases 17
Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic 18F-FDG-PET Study 16
Monte Carlo 90Y PET/CT dosimetry of unexpected focal radiation-induced lung damage after hepatic radioembolisation 16
Quantification of dose nonuniformities by voxel-based dosimetry in patients receiving 90Y-ibritumomab-tiuxetan 16
Visual and quantitative approach to bone marrow foci of increased glucose uptake on PET/CT in a case of aplastic anaemia 16
Elevated whole blood viscosity is associated with an impaired insulin-stimulated myocardial glucose metabolism 16
Sex-specific differences in myocardial glucose metabolic rate in non-diabetic, pre-diabetic and type 2 diabetic subjects 15
Translating the theranostic concept to neuro-oncology: disrupting barriers 14
Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck 14
Studying the metabolic activity of red bone marrow by means of FDG-PET: The need for a standardization 13
Functional connectivity of the cortico-subcortical sensorimotor loop is modulated by the severity of nigrostriatal dopaminergic denervation in Parkinson’s Disease 12
LONGITUDINAL BRAIN VOLUME AND GLUCOSE METABOLISM CHANGES IN PATIENTS WITH JUVENILE-ONSET HUNTINGTON DISEASE 12
Editorial: "Nuclear medicine in cancer diagnosis" 12
Erratum: Tc-99m DTPA cisternography shows disappearance of cerebrospinal fluid leakage after standing a short time (Clinical Nuclear Medicine (2009)(29-30)) 11
Pediatric Huntington Disease Brains Have Distinct Morphologic and Metabolic Traits: the RAREST‐JHD Study 10
Totale 2.734
Categoria #
all - tutte 35.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.469


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021156 0 0 0 8 5 94 10 18 6 10 1 4
2021/2022378 13 2 7 161 20 2 6 52 21 49 22 23
2022/2023523 152 44 7 46 50 32 10 35 65 33 35 14
2023/2024322 58 27 25 25 17 54 12 21 11 29 31 12
2024/2025898 125 15 18 27 81 122 29 30 140 47 108 156
2025/2026414 103 300 11 0 0 0 0 0 0 0 0 0
Totale 2.734